ZEISS ends successful fiscal year 2012/13
In fiscal year 2012/13 different developments were observed in the market segments relevant to ZEISS. Overall, the market situation was tense: while slight growth was reported in the market for medical technology, the markets for microscopy, industrial metrology and eyeglass lenses remained stable. Demand in the market for lithography systems continued to decline in the first half of the fiscal year compared to the previous year, but picked up again in the second half. "In fiscal year 2012/13 we reached and partly exceeded our targets. ZEISS put in a good performance despite the challenging business environment and the weakness of the economy at the beginning of the year," said Dr. Michael Kaschke, President and CEO of Carl Zeiss AG. "We made no compromises in our multi-year investment program – the biggest ever in the company's history – but continued to implement it consistently and systematically.“
Most read news
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.